CUDC-427

CAS: 1446182-94-0

Ref. 3D-WHC18294

Produktinformation

• Name: CUDC-427

Beschreibung

CUDC-427 is a small molecule drug that selectively inhibits the growth of tumor cells by inducing apoptosis. It has shown efficacy in preclinical studies for the treatment of adrenocortical carcinoma, fibrolamellar carcinoma, and skin cancer. CUDC-427 has been shown to have predictive biomarker properties and clinical relevance as an effective anti-cancer agent. This drug has also been shown to have toxicities in preclinical studies, which may limit its therapeutic use.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 564.7 g/mol
• Formel: C₂₉H₃₆N₆O₄S
• Reinheit: Min. 95%